Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Abhijeet Lokras"'
Autor:
Abhijeet Lokras, Aneesh Thakur, Abishek Wadhwa, Kaushik Thanki, Henrik Franzyk, Camilla Foged
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2021)
RNA interference (RNAi) has an unprecedented potential as a therapeutic strategy for reversibly silencing the expression of any gene. Therapeutic delivery of the RNAi mediator, i.e., small interfering RNA (siRNA), can be used to address diseases char
Externí odkaz:
https://doaj.org/article/5769adcc7a7d4afe8b6c9ab66fafbf57
Publikováno v:
Pharmaceutics, Vol 12, Iss 2, p 102 (2020)
In the past few years, there has been increasing focus on the use of messenger RNA (mRNA) as a new therapeutic modality. Current clinical efforts encompassing mRNA-based drugs are directed toward infectious disease vaccines, cancer immunotherapies, t
Externí odkaz:
https://doaj.org/article/0448043441a7465b892b92f6d65c2b5a
Autor:
Aneesh Thakur, Abishek Wadhwa, Abhijeet Lokras, Olivia Amanda Oest Müllertz, Dennis Christensen, Henrik Franzyk, Camilla Foged
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics.
Autor:
Abhijeet Lokras, Akash Chakravarty, Thomas Rades, Dennis Christensen, Henrik Franzyk, Aneesh Thakur, Camilla Foged
Publikováno v:
Lokras, A G, Chakravarty, A, Rades, T, Christensen, D, Franzyk, H, Thakur, A & Foged, C 2022, ' Simultaneous quantification of multiple RNA cargoes co-loaded into nanoparticle-based delivery systems ', International Journal of Pharmaceutics, vol. 626, 122171 . https://doi.org/10.1016/j.ijpharm.2022.122171
Robust, sensitive, and versatile analytical methods are essential for quantification of RNA drug cargoes loaded into nanoparticle-based delivery systems. However, simultaneous quantification of multiple RNA cargoes co-loaded into nanoparticles remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b92ba552f75e832293f398d2e715ff0
https://curis.ku.dk/ws/files/319401574/1_s2.0_S0378517322007256_main.pdf
https://curis.ku.dk/ws/files/319401574/1_s2.0_S0378517322007256_main.pdf
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2282
Therapy based on RNA interference (RNAi), which can be mediated by exogenous small interfering RNA (siRNA), has potential for the management of diseases at the genetic level by silencing gene function(s). In all eukaryotic cells, RNAi is an endogenou
Autor:
Kaushik Thanki, Abishek Wadhwa, Henrik Franzyk, Camilla Foged, Aneesh Thakur, Abhijeet Lokras
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2021)
Lokras, A, Thakur, A, Wadhwa, A, Thanki, K, Franzyk, H & Foged, C 2020, ' Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles ', Frontiers in Bioengineering and Biotechnology, vol. 8, 601155 . https://doi.org/10.3389/fbioe.2020.601155
Frontiers in Bioengineering and Biotechnology
Lokras, A, Thakur, A, Wadhwa, A, Thanki, K, Franzyk, H & Foged, C 2020, ' Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles ', Frontiers in Bioengineering and Biotechnology, vol. 8, 601155 . https://doi.org/10.3389/fbioe.2020.601155
Frontiers in Bioengineering and Biotechnology
RNA interference (RNAi) has an unprecedented potential as a therapeutic strategy for reversibly silencing the expression of any gene. Therapeutic delivery of the RNAi mediator, i.e., small interfering RNA (siRNA), can be used to address diseases char
Publikováno v:
Methods in Molecular Biology ISBN: 9781071612972
Therapy based on RNA interference (RNAi), which can be mediated by exogenous small interfering RNA (siRNA), has potential for the management of diseases at the genetic level by silencing gene function(s). In all eukaryotic cells, RNAi is an endogenou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c1b4a1a150c08827b3ef311d0639032
https://doi.org/10.1007/978-1-0716-1298-9_9
https://doi.org/10.1007/978-1-0716-1298-9_9
Publikováno v:
Pharmaceutics, Vol 12, Iss 2, p 102 (2020)
Pharmaceutics
Wadhwa, A, Aljabbari, A, Lokras, A, Foged, C & Thakur, A 2020, ' Opportunities and Challenges in the Delivery of mRNA-based Vaccines ', Pharmaceutics, vol. 12, no. 2, 102 . https://doi.org/10.3390/pharmaceutics12020102
Pharmaceutics
Wadhwa, A, Aljabbari, A, Lokras, A, Foged, C & Thakur, A 2020, ' Opportunities and Challenges in the Delivery of mRNA-based Vaccines ', Pharmaceutics, vol. 12, no. 2, 102 . https://doi.org/10.3390/pharmaceutics12020102
In the past few years, there has been increasing focus on the use of messenger RNA (mRNA) as a new therapeutic modality. Current clinical efforts encompassing mRNA-based drugs are directed toward infectious disease vaccines, cancer immunotherapies, t
Autor:
Madhusudan Saraf, Brijesh Sutariya, U. Warawdekar, Mukul Ashtikar, Vivek Dhawan, Jiten H Shah, M. Krishnapriya, Frank Steiniger, Kalpa Nagarsekar, Abhijeet Lokras, Alfred Fahr, Mangal S. Nagarsenker, G.V. Joshi
Publikováno v:
Carbohydrate Research. 509:108417
Ligands with the polysaccharide headgroups have been recently reported by our group to possess enhanced interaction with asialoglycoprotein receptor (ASGPR) in silico as compared to ligands having galactose moieties. This enhanced interaction is a re
Autor:
Abhijeet Lokras, Guillermo Cano-Garcia, Fabrice Rose, Henrik Franzyk, Kaushik Thanki, Cypriane Dormenval, Aneesh Thakur, Camilla Foged, Abishek Wadhwa
Publikováno v:
Pharmaceutical research. 36(10)
Background With the recent approval of the first small interfering RNA (siRNA) therapeutic formulated as nanoparticles, there is increased incentive for establishing the factors of importance for the design of stable solid dosage forms of such comple